First Header Logo Second Header Logo

Elizabeth Palavecino

Concepts (313)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Staphylococcal Infections
10
2020
76
3.090
Why?
Bacteremia
7
2023
65
2.990
Why?
Anti-Bacterial Agents
20
2023
324
2.950
Why?
Methicillin-Resistant Staphylococcus aureus
5
2020
32
2.350
Why?
Microbial Sensitivity Tests
16
2023
80
1.770
Why?
Staphylococcus
2
2023
10
1.670
Why?
Methicillin Resistance
5
2023
22
1.540
Why?
Staphylococcus aureus
8
2023
53
1.510
Why?
Bacteriological Techniques
9
2018
17
1.480
Why?
Pseudomonas aeruginosa
2
2020
35
1.440
Why?
Bacterial Proteins
5
2022
90
1.160
Why?
Humans
60
2023
32024
1.160
Why?
Bacteria
5
2018
48
1.090
Why?
beta-Lactamases
3
2022
13
1.070
Why?
Pneumocystis carinii
2
2020
6
1.040
Why?
Epstein-Barr Virus Infections
2
2022
10
0.990
Why?
Gonorrhea
2
2020
12
0.900
Why?
Cross Infection
4
2019
55
0.890
Why?
BK Virus
1
2022
6
0.870
Why?
Klebsiella pneumoniae
2
2020
14
0.870
Why?
Polyomavirus Infections
1
2022
21
0.850
Why?
Acinetobacter baumannii
1
2022
6
0.840
Why?
Influenza, Human
3
2019
122
0.830
Why?
Diagnostic Errors
3
2012
44
0.830
Why?
Penicillin-Binding Proteins
2
2020
3
0.830
Why?
Hematopoietic Stem Cell Transplantation
1
2022
94
0.820
Why?
Reagins
1
2022
3
0.810
Why?
Syphilis
1
2022
10
0.810
Why?
Neisseria gonorrhoeae
2
2020
8
0.770
Why?
Pseudomonas Infections
1
2020
14
0.750
Why?
Drug Contamination
2
2018
6
0.720
Why?
Azithromycin
1
2020
15
0.720
Why?
Kidney Transplantation
2
2022
517
0.720
Why?
beta-Lactam Resistance
1
2020
2
0.710
Why?
Cytomegalovirus
1
2020
30
0.700
Why?
Bronchoalveolar Lavage Fluid
1
2020
70
0.690
Why?
Blood Platelets
4
2009
39
0.690
Why?
Communicable Diseases
1
2019
20
0.690
Why?
Immunocompromised Host
5
2020
51
0.690
Why?
Syringes
1
2018
5
0.660
Why?
Antifungal Agents
5
2018
40
0.650
Why?
Anesthetics
1
2018
18
0.650
Why?
Operating Rooms
1
2018
35
0.640
Why?
Strongyloidiasis
1
2017
3
0.610
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2017
18
0.600
Why?
Drug Resistance, Bacterial
3
2020
47
0.560
Why?
Gram-Negative Bacteria
2
2013
8
0.500
Why?
Gram-Negative Bacterial Infections
2
2013
14
0.490
Why?
Molecular Diagnostic Techniques
3
2020
11
0.470
Why?
Clinical Laboratory Techniques
3
2021
24
0.450
Why?
Platelet Transfusion
4
2009
16
0.440
Why?
Shiga Toxin
1
2012
2
0.440
Why?
Shiga-Toxigenic Escherichia coli
1
2012
3
0.440
Why?
Chromatography, Affinity
1
2012
15
0.440
Why?
Daptomycin
1
2012
2
0.430
Why?
Enterococcus faecalis
1
2012
12
0.430
Why?
Feces
1
2012
40
0.430
Why?
Enterococcus faecium
1
2012
5
0.430
Why?
Escherichia coli Infections
1
2012
39
0.420
Why?
Fatal Outcome
6
2018
82
0.410
Why?
Carbapenems
2
2022
7
0.400
Why?
Mycoses
2
2011
21
0.400
Why?
Fungi
1
2011
9
0.380
Why?
Laboratories, Hospital
1
2010
3
0.360
Why?
Pathology, Molecular
1
2010
16
0.360
Why?
Bacterial Infections
3
2006
52
0.360
Why?
Mycobacterium Infections
1
2010
1
0.360
Why?
Corynebacterium Infections
1
2010
3
0.360
Why?
Mycobacterium
1
2010
3
0.360
Why?
Endocarditis, Bacterial
1
2010
10
0.360
Why?
Herpesvirus 4, Human
2
2022
9
0.340
Why?
Bone Marrow Diseases
1
2009
2
0.340
Why?
Pneumocystis Infections
1
2009
2
0.340
Why?
Lymphoma, T-Cell, Cutaneous
1
2009
4
0.340
Why?
United States
8
2020
3938
0.330
Why?
Male
16
2020
19195
0.330
Why?
Bone Marrow
1
2009
70
0.320
Why?
Time Factors
6
2018
2152
0.310
Why?
Amphotericin B
3
2018
12
0.310
Why?
Lung Diseases, Fungal
2
2018
7
0.310
Why?
Drug Resistance, Microbial
3
2022
14
0.310
Why?
Adult
13
2020
9366
0.300
Why?
Polymerase Chain Reaction
2
2021
197
0.300
Why?
Blood Transfusion
2
2004
74
0.290
Why?
Influenza A virus
2
2019
22
0.290
Why?
Drug Resistance, Fungal
2
2003
3
0.280
Why?
Fluconazole
2
2003
8
0.280
Why?
Child, Preschool
4
2020
1269
0.260
Why?
Female
18
2020
19953
0.260
Why?
Erythromycin
2
2002
7
0.260
Why?
Sepsis
2
2004
158
0.260
Why?
Sensitivity and Specificity
4
2020
594
0.250
Why?
Blood Component Transfusion
1
2004
10
0.250
Why?
Streptococcus pyogenes
2
2003
16
0.250
Why?
Seasons
2
2019
87
0.240
Why?
DNA, Viral
2
2022
54
0.240
Why?
Streptococcal Infections
2
2003
22
0.240
Why?
Laboratories
1
2023
15
0.230
Why?
Middle Aged
11
2019
11868
0.230
Why?
Length of Stay
2
2023
318
0.230
Why?
Costs and Cost Analysis
1
2023
100
0.220
Why?
Candidiasis
1
2003
5
0.220
Why?
AIDS-Related Opportunistic Infections
1
2003
9
0.220
Why?
Candida albicans
1
2003
12
0.220
Why?
Esophageal Diseases
1
2003
7
0.220
Why?
Mitosporic Fungi
1
2003
2
0.220
Why?
Cephalosporins
1
2023
9
0.220
Why?
Antibodies, Bacterial
2
2022
32
0.220
Why?
Viral Load
1
2022
70
0.210
Why?
Drug Resistance, Multiple, Bacterial
1
2022
21
0.210
Why?
Pneumonia
2
2020
67
0.210
Why?
Streptococcus pneumoniae
1
2002
40
0.210
Why?
Cell Culture Techniques
2
2014
174
0.210
Why?
Syphilis Serodiagnosis
1
2022
4
0.200
Why?
Treponema pallidum
1
2022
7
0.200
Why?
Animals
4
2020
7466
0.200
Why?
Immunoassay
1
2021
16
0.190
Why?
Carrier State
1
2020
23
0.190
Why?
Bacterial Typing Techniques
2
2014
17
0.190
Why?
Membrane Proteins
1
2002
257
0.190
Why?
Antibodies, Viral
1
2020
58
0.180
Why?
Cerebrospinal Fluid Otorrhea
1
2020
3
0.180
Why?
Cefixime
1
2020
4
0.180
Why?
HIV Seronegativity
1
2020
6
0.180
Why?
Osteomyelitis
1
2020
22
0.180
Why?
Pharynx
1
2020
14
0.180
Why?
Penicillins
1
2020
11
0.180
Why?
Tetracycline
1
2020
13
0.180
Why?
Ceftriaxone
1
2020
14
0.180
Why?
Arthritis, Infectious
1
2020
24
0.180
Why?
Virology
1
2020
1
0.180
Why?
Mycological Typing Techniques
1
2020
1
0.180
Why?
Bronchoalveolar Lavage
1
2020
14
0.180
Why?
Oxacillin
1
2020
4
0.180
Why?
Hospitals
1
2020
103
0.180
Why?
Pneumonia, Pneumocystis
1
2020
6
0.180
Why?
Cytomegalovirus Infections
1
2020
48
0.170
Why?
Enterobacteriaceae
2
2017
11
0.170
Why?
Health Facilities
1
2019
9
0.170
Why?
Clindamycin
3
2007
22
0.170
Why?
North Carolina
3
2020
1516
0.170
Why?
Drug Packaging
1
2018
5
0.160
Why?
Homosexuality, Male
1
2020
84
0.160
Why?
Blood Preservation
3
2009
11
0.160
Why?
Child
6
2016
2441
0.160
Why?
Ascomycota
1
2018
4
0.160
Why?
Diagnosis, Differential
1
2020
518
0.150
Why?
Strongyloides stercoralis
1
2017
3
0.150
Why?
Piperacillin
1
2017
6
0.150
Why?
Penicillanic Acid
1
2017
6
0.150
Why?
Antiparasitic Agents
1
2017
6
0.150
Why?
Cryptococcosis
1
2017
5
0.150
Why?
Ivermectin
1
2017
9
0.150
Why?
Pharmacists
1
2018
20
0.150
Why?
Plateletpheresis
2
2009
3
0.150
Why?
Physicians
1
2019
158
0.150
Why?
Case-Control Studies
1
2020
897
0.150
Why?
Colony Count, Microbial
3
2010
18
0.140
Why?
Culture Media
2
2009
47
0.140
Why?
Aged
5
2019
10340
0.140
Why?
Predictive Value of Tests
3
2020
878
0.140
Why?
Sphingomonas
1
2015
3
0.130
Why?
Meningitis
1
2015
9
0.130
Why?
Virulence
2
2007
22
0.130
Why?
Practice Guidelines as Topic
1
2018
407
0.130
Why?
Influenza A Virus, H1N1 Subtype
1
2016
47
0.130
Why?
Community-Acquired Infections
2
2007
31
0.130
Why?
Adolescent
5
2016
3526
0.130
Why?
Anemia, Hemolytic, Autoimmune
1
2015
4
0.130
Why?
Mucormycosis
1
2014
2
0.120
Why?
Autoantibodies
1
2015
49
0.120
Why?
Nucleic Acid Amplification Techniques
1
2014
10
0.120
Why?
Influenza B virus
1
2014
20
0.120
Why?
Young Adult
4
2016
2615
0.120
Why?
Chile
3
2006
7
0.120
Why?
Electrophoresis
1
2014
7
0.120
Why?
Multiple Organ Failure
2
2014
10
0.120
Why?
Fluorescent Antibody Technique
1
2014
91
0.110
Why?
Microscopy, Fluorescence
1
2014
88
0.110
Why?
Computational Biology
1
2014
91
0.110
Why?
United States Food and Drug Administration
2
2020
45
0.110
Why?
Diabetes Complications
1
2014
177
0.110
Why?
Hematuria
1
2012
11
0.110
Why?
Lactobacillus
1
2012
14
0.110
Why?
Urinalysis
1
2012
27
0.110
Why?
Diabetes Mellitus, Type 1
1
2014
251
0.110
Why?
Gentamicins
1
2012
5
0.100
Why?
Peritonitis
1
2012
14
0.100
Why?
Mupirocin
1
2012
3
0.100
Why?
Catheter-Related Infections
1
2012
10
0.100
Why?
Anti-Infective Agents, Local
1
2012
15
0.100
Why?
Antibiotic Prophylaxis
1
2012
37
0.100
Why?
Peritoneal Dialysis
1
2012
26
0.100
Why?
Hyphae
1
2011
1
0.100
Why?
Cerebrospinal Fluid
1
2011
17
0.100
Why?
Unnecessary Procedures
1
2011
16
0.100
Why?
Cushing Syndrome
1
2010
1
0.090
Why?
Nocardia asteroides
1
2010
2
0.090
Why?
Carcinoid Tumor
1
2010
14
0.090
Why?
Rifampin
1
2010
8
0.090
Why?
Staphylococcus epidermidis
1
2010
6
0.090
Why?
Ventriculostomy
1
2010
11
0.090
Why?
Cerebrospinal Fluid Shunts
1
2010
7
0.090
Why?
Minocycline
1
2010
11
0.090
Why?
Urine
1
2011
64
0.090
Why?
Coated Materials, Biocompatible
1
2010
18
0.090
Why?
Education, Continuing
1
2010
6
0.090
Why?
Mass Screening
1
2012
264
0.090
Why?
Organizational Innovation
1
2010
31
0.090
Why?
Calorimetry
1
2009
4
0.090
Why?
Blood
1
2009
14
0.090
Why?
Phlebotomy
1
2009
16
0.090
Why?
Equipment Contamination
1
2009
12
0.090
Why?
Geotrichosis
1
2009
1
0.090
Why?
Geotrichum
1
2009
1
0.090
Why?
Echinocandins
1
2009
6
0.090
Why?
Lipopeptides
1
2009
6
0.090
Why?
Neutropenia
1
2009
30
0.090
Why?
Phenotype
2
2002
639
0.090
Why?
DNA, Bacterial
2
2007
27
0.090
Why?
Bacterial Capsules
1
2009
4
0.080
Why?
Microscopy, Atomic Force
1
2009
5
0.080
Why?
Bacterial Adhesion
1
2009
6
0.080
Why?
Respiratory Syncytial Virus, Human
1
2008
3
0.080
Why?
Respiratory Syncytial Virus Infections
1
2008
10
0.080
Why?
Spleen
1
2009
86
0.080
Why?
Ustilaginales
1
2008
3
0.080
Why?
Fungemia
1
2008
3
0.080
Why?
Short Bowel Syndrome
1
2008
16
0.080
Why?
Antiviral Agents
1
2008
108
0.080
Why?
Skin
1
2009
210
0.070
Why?
Catheterization, Central Venous
1
2008
62
0.070
Why?
Molecular Epidemiology
1
2007
20
0.070
Why?
Vancomycin Resistance
1
2007
8
0.070
Why?
Evolution, Molecular
1
2007
34
0.070
Why?
Antibodies, Monoclonal
1
2008
244
0.070
Why?
Lung Neoplasms
1
2010
409
0.070
Why?
Disease Reservoirs
1
2006
2
0.070
Why?
Hospitals, University
1
2006
32
0.070
Why?
Bartonella henselae
1
2006
2
0.070
Why?
Serotyping
2
2003
19
0.070
Why?
Quality Control
1
2006
44
0.070
Why?
Cats
1
2006
108
0.070
Why?
Electrophoresis, Gel, Pulsed-Field
2
2003
11
0.060
Why?
Blood Donors
1
2004
14
0.060
Why?
Contact Tracing
2
2020
9
0.060
Why?
Clostridium difficile
1
2004
12
0.060
Why?
Intestinal Diseases
1
2004
16
0.060
Why?
Clostridium Infections
1
2004
9
0.060
Why?
Methicillin
1
2004
3
0.060
Why?
Sterilization
1
2003
2
0.060
Why?
Erythrocytes
1
2003
48
0.060
Why?
Pharyngeal Diseases
1
2003
9
0.060
Why?
Candidiasis, Oral
1
2003
10
0.060
Why?
Cryptococcus neoformans
1
2003
2
0.060
Why?
Candida
1
2003
7
0.060
Why?
CD4 Lymphocyte Count
1
2003
32
0.060
Why?
Risk Factors
2
2018
3869
0.050
Why?
Methyltransferases
1
2002
5
0.050
Why?
Phenazines
1
2002
1
0.050
Why?
Serologic Tests
1
2002
11
0.050
Why?
Gentian Violet
1
2002
3
0.050
Why?
False Negative Reactions
1
2002
20
0.050
Why?
Prospective Studies
3
2014
2283
0.050
Why?
Infant
2
2016
1061
0.050
Why?
Antibodies, Neutralizing
1
2020
19
0.050
Why?
Immunoglobulin G
2
2015
121
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2001
261
0.050
Why?
Alternaria
1
2018
1
0.040
Why?
Patient Care Management
1
2018
18
0.040
Why?
Knee
1
2018
33
0.040
Why?
Biopsy, Fine-Needle
1
2017
53
0.040
Why?
Program Evaluation
1
2018
186
0.040
Why?
Patient Care Team
1
2018
130
0.040
Why?
Attitude of Health Personnel
1
2018
182
0.030
Why?
Disease Outbreaks
2
2008
43
0.030
Why?
Aged, 80 and over
2
2014
4000
0.030
Why?
Cryoglobulins
1
2015
5
0.030
Why?
Erythrocyte Transfusion
1
2015
35
0.030
Why?
Reproducibility of Results
1
2017
765
0.030
Why?
Infant, Newborn
1
2016
673
0.030
Why?
Reagent Strips
1
2012
4
0.030
Why?
False Positive Reactions
1
2012
31
0.030
Why?
Pseudomonas
1
2012
6
0.030
Why?
Emergency Service, Hospital
1
2016
473
0.030
Why?
Survival Analysis
1
2013
488
0.020
Why?
Retrospective Studies
2
2012
3523
0.020
Why?
Nocardia Infections
1
2010
2
0.020
Why?
Adrenocorticotropic Hormone
1
2010
19
0.020
Why?
Prosthesis-Related Infections
1
2010
22
0.020
Why?
Agar
1
2009
1
0.020
Why?
Chromogenic Compounds
1
2009
1
0.020
Why?
Color
1
2009
12
0.020
Why?
Surface Properties
1
2009
32
0.020
Why?
Magnetic Resonance Imaging
1
2015
1324
0.020
Why?
Water
1
2009
56
0.020
Why?
Population Surveillance
1
2008
125
0.020
Why?
Cohort Studies
1
2012
1831
0.020
Why?
Models, Biological
1
2009
391
0.020
Why?
Blood-Borne Pathogens
1
2006
8
0.020
Why?
Seroepidemiologic Studies
1
2006
10
0.020
Why?
Fluorescent Antibody Technique, Indirect
1
2006
14
0.020
Why?
Chi-Square Distribution
1
2006
298
0.020
Why?
Evaluation Studies as Topic
1
2005
45
0.020
Why?
Treatment Outcome
1
2013
3317
0.020
Why?
Pharyngitis
1
2003
10
0.010
Why?
Empyema, Pleural
1
2003
7
0.010
Why?
Disease Transmission, Infectious
1
2003
17
0.010
Why?
Pneumonia, Bacterial
1
2003
32
0.010
Why?
Shock, Septic
1
2003
26
0.010
Why?
Family Health
1
2003
76
0.010
Why?
Drug Therapy, Combination
1
2003
286
0.010
Why?
Genotype
1
2003
734
0.010
Why?
Palavecino's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (313)
Explore
_
Co-Authors (28)
Explore
_
Similar People (51)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_